Veru Inc.
VERU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000863894
In the last 90 days, Veru Inc. insiders filed 1 open-market purchase and 0 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $9.45M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Veru Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- +14 vs. Q3 2024
- Shares held
- 57.2M
- −2.86M (−4.8%) vs. Q3 2024
- Total value
- $37.2M
- −$8.96M (−19.4%) vs. Q3 2024
- New holders
- 25
- 37 more added
- Sold out
- 11
- 25 more reduced
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $9.45M |
| Q1 2026 | 59 | $7.77M |
| Q4 2025 | 53 | $7.63M |
| Q3 2025 | 65 | $12.6M |
| Q2 2025 | 126 | $21.7M |
| Q1 2025 | 131 | $23.3M |
| Q4 2024 | 124 | $37.2M |
| Q3 2024 | 113 | $46.2M |
| Q2 2024 | 107 | $51.2M |
| Q1 2024 | 94 | $33.5M |
| Q4 2023 | 90 | $43.1M |
| Q3 2023 | 63 | $9.34M |
| Q2 2023 | 84 | $18.9M |
| Q1 2023 | 108 | $37.3M |
| Q4 2022 | 131 | $246.2M |
| Q3 2022 | 142 | $454.0M |
| Q2 2022 | 131 | $509.5M |
| Q1 2022 | 98 | $110.3M |
| Q4 2021 | 111 | $137.3M |
| Q3 2021 | 110 | $208.4M |
| Q2 2021 | 111 | $196.8M |
| Q1 2021 | 110 | $286.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Veru Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prelude Capital Management, LLC | 331,800 | $215.8K | 0.02% | +331,800 | New |
| Blair William & Co | 350,000 | $227.7K | 0.00% | 00.0% | Unchanged |
| RSM US Wealth Management LLC | 399,777 | $260.0K | 0.00% | +85,584+27.2% | Added |
| Envestnet Asset Management Inc | 406,755 | $264.6K | 0.00% | +75,997+23.0% | Added |
| Citadel Advisors LLC | 412,821 | $268.5K | 0.00% | +412,821 | New |
| UBS Group AG | 448,565 | $291.6K | 0.00% | +384,138+596.2% | Added |
| Alpine Global Management, LLC | 610,070 | $396.9K | 0.12% | −39,930−6.1% | Reduced |
| Ikarian Capital, LLC | 945,239 | $614.9K | 0.18% | −1,143−0.1% | Reduced |
| Northern Trust Corp | 1,029,174 | $669.5K | 0.00% | −28,730−2.7% | Reduced |
| PVG Asset Management Corp | 1,047,310 | $681.3K | 3.22% | +410,340+64.4% | Added |
| Deutsche Bank AG | 1,101,296 | $715.8K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 1,120,586 | $728.9K | 0.01% | +722,644+181.6% | Added |
| Exome Asset Management LLC | 1,117,600 | $739.5K | 0.56% | +1,117,600 | New |
| Cambridge Investment Research Advisors, Inc. | 1,216,674 | $791.0K | 0.00% | +398,139+48.6% | Added |
| Morgan Stanley | 1,464,099 | $952.4K | 0.00% | −1,550,534−51.4% | Reduced |
| Altium Capital Management LP | 2,028,534 | $1.32M | 0.41% | 00.0% | Unchanged |
| State Street Corp | 2,279,031 | $1.48M | 0.00% | +206,966+10.0% | Added |
| Adage Capital Partners GP, L.L.C. | 2,300,000 | $1.50M | 0.00% | −5,561,111−70.7% | Reduced |
| Geode Capital Management, LLC | 2,997,751 | $1.95M | 0.00% | +57,611+2.0% | Added |
| Millennium Management LLC | 3,764,609 | $2.45M | 0.00% | −1,790,198−32.2% | Reduced |
| MPM Oncology Impact Management LP | 4,285,365 | $2.79M | 0.40% | +4,285,365 | New |
| Vanguard Group Inc | 6,219,786 | $4.05M | 0.00% | +19,058+0.3% | Added |
| Perceptive Advisors LLC | 6,483,157 | $4.22M | 0.12% | −800,000−11.0% | Reduced |
| BlackRock, Inc. | 8,311,002 | $5.41M | 0.00% | +75,732+0.9% | Added |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −2,694,503−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −142,381−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −33,058−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −21,904−100.0% | Sold out |
| Wealth Quarterback LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −15,986−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −14,274−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,837−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −378−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −691−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |
| Pegasus Partners Ltd. | – | – | – | – | Not filed |